A New Drug May Be Coming to the Market for Cutaneous T-cell Lymphoma
https://pixabay.com/en/youth-active-jump-happy-sunrise-570881/

A New Drug May Be Coming to the Market for Cutaneous T-cell Lymphoma

A phase 3 clinical trial has produced positive results for cutaneous T-cell lymphoma (CTCL) patients. The drug tested is called brentuximab vedotin (Adcetris). Specifically, the drug was created to treat…

Continue Reading A New Drug May Be Coming to the Market for Cutaneous T-cell Lymphoma